<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="possibly involved in viral entry, proliferation, and survival to establish" exact="infection" post="and facilitate disease progression. Our probabilistic modeling framework elucidates"/>
 <result pre="to Generate Calu-3-Specific Human-SARS-CoV-2 Interactome Likely, the outcome of SARS-CoV-2" exact="infection" post="can largely be determined by the interaction patterns of"/>
 <result pre="the Host Network From the network biology standpoint, a viral" exact="infection" post="as well as other pathogen attacks can be viewed"/>
 <result pre="are implicated in core molecular and cellular pathways to establish" exact="infection" post="and continue disease progress. FigureÂ 2 SARS-CoV-2 Interacting Proteins"/>
 <result pre="might be largely relevant to modifying host response following SARS-CoV-2" exact="infection" post="(FigureÂ 3E). Moreover, the proteins in the other two"/>
 <result pre="with our CSI data (Xiong etÂ al., 2020). Overall, SARS-CoV-2" exact="infection" post="exhibited largely different transcriptional signatures for BALF cells and"/>
 <result pre="CSPs exhibit a strong positive correlation between SARS-CoV and SARS-CoV-2" exact="infection" post="at both 12Â h (r2Â = 0.973) and 24Â"/>
 <result pre="of 5,495 cumulative DEGs in SARS-CoV-2 across 24Â h of" exact="infection" post="reconstructed by incorporating static protein-DNA interaction, microRNA (miRNA)/target interaction"/>
 <result pre="target genes of SARS-CoV-2 unique regulator across 24Â h of" exact="infection" post="in Calu-3 cells. (H) The expression patterns of hsa-miR-429"/>
 <result pre="expression patterns of hsa-miR-429 target genes in response to SARS-CoV-2" exact="infection" post="at the indicated time points. The enriched pathways are"/>
 <result pre="analysis of cytokine-storm-related genes in response to SARS-CoV and SARS-CoV-2" exact="infection" post="at the indicated time. â€œSee also Figures S2, S3,"/>
 <result pre="for numerous genes, thereby distinguishing the progression of disease upon" exact="infection" post="with these two coronaviruses (FigureÂ 4F). Furthermore, to understand"/>
 <result pre="the target genes of these regulators is increasing during SARS-CoV-2" exact="infection" post="(FigureÂ 4G). Here, we also found that hsa-miR-429, which"/>
 <result pre="hsa-miR-429 can potentially regulate over 750 genes involved in SARS-CoV-2" exact="infection" post="(Table S4). Intriguingly, 573 of these 752 hsa-miR-429 target"/>
 <result pre="the aforementioned pathways' genes at various stages of the SARS-CoV-2" exact="infection" post="in COVID-19 patients. Finally, we showed distinct patterns of"/>
 <result pre="we showed distinct patterns of key pathway genes in SARS-CoV-2" exact="infection" post="when compared with SARS-CoV and other respiratory viruses. Translational"/>
 <result pre="believe that effective and prompt therapeutic strategies for blocking SARS-CoV-2" exact="infection" post="are not straight forward. Notably, keeping in view the"/>
 <result pre="in view the long asymptomatic latency of virus infection, single-agent" exact="treatment" post="could at the most be marginally or partially effective,"/>
 <result pre="on the stage of the disease progression. However, combinatorial drug" exact="treatment" post="approaches developed logically based on the potential inhibition of"/>
 <result pre="drugs is also used for the effective management of HIV-1" exact="infection" post="in humans (Pemovska etÂ al., 2018; Pirrone etÂ al.,"/>
 <result pre="Recently, the global posttranslational modification landscape in response to SARS-CoV-2" exact="infection" post="indicated an increase in the phosphorylation of NUP98, a"/>
 <result pre="that UPS plays crucial roles at multiple stages of coronavirus" exact="infection" post="(Raaben etÂ al., 2010). In our study, the ubiquitin"/>
 <result pre="regulation of apoptosis. Indeed, it was recently reported that SARS-CoV-2" exact="infection" post="may cause lymphocyte apoptosis demonstrated by overall cell count"/>
 <result pre="2020), it is quite interesting that pathogenesis of the viral" exact="infection" post="is not significantly different between the populations of hypertensive"/>
 <result pre="significant CSP in our study, which is altered by SARS-CoV-2" exact="infection" post="and plays key roles in regulating oxidative and inflammatory"/>
 <result pre="of transcriptome-wide differences. Also, a detailed temporal dataset of SARS-CoV-2" exact="infection" post="to death/recovery host transcriptome is lacking, which may provide"/>
 <result pre="provide immense clarity in activated regulators during different stages of" exact="infection" post="and death/recovery. Finally, we may expect additional drug-protein interactions"/>
 <result pre="and control of COVID-19 epidemicsNat. Med.2620201205121132546824 de ChasseyB.NavratilV.TafforeauL.HietM.S.Aublin-GexA.AgaugueS.MeiffrenG.PradezynskiF.FariaB.F.ChantierT.Hepatitis C virus" exact="infection" post="protein networkMol. Syst. Biol.4200823018985028 DevkotaP.DanziM.C.WuchtyS.Beyond degree and betweenness centrality:"/>
 <result pre="conditions in coronavirus disease 2019 (COVID-19): important considerations regarding novel" exact="treatment" post="strategies to reduce mortalityMed. Hypotheses140202010976032344310 GenetetS.DesramesA.ChoualiY.RipocheP.LopezC.Mouro-ChanteloupI.Stomatin modulates the activity"/>
 <result pre="system be withdrawn in patients with COVID-19?Eur. Heart J.4120201801180332196087 LiG.HuR.ZhangX.Antihypertensive" exact="treatment" post="with ACEI/ARB of patients with COVID-19 complicated by hypertensionHypertens."/>
 <result pre="networks for infectious diseasesBrief. Bioinform.17201651752626261187 PemovskaT.BigenzahnJ.W.Superti-FurgaG.Recent advances in combinatorial drug" exact="screening" post="and synergy scoringCurr. Opin. Pharmacol.42201810211030193150 PfefferleS.SchopfJ.KoglM.FriedelC.C.MullerM.A.Carbajo-LozoyaJ.StellbergerT.von Dall'ArmiE.HerzogP.KalliesS.The SARS-coronavirus-host interactome:"/>
 <result pre="for pan-coronavirus inhibitorsPlos Pathog.72011e100233122046132 PirroneV.ThakkarN.JacobsonJ.M.WigdahlB.KrebsF.C.Combinatorial approaches to the prevention and" exact="treatment" post="of HIV-1 infectionAntimicrob. Agents Chemother.5520111831184221343462 PrasharA.SchnettgerL.BernardE.M.GutierrezM.G.Rab GTPases in immunity"/>
 <result pre="plays an important role during various stages of the coronavirus" exact="infection" post="cycleJ.Â Virol.8420107869787920484504 Resa-InfanteP.BonetJ.ThieleS.AlawiM.Stanelle-BertramS.TukuB.BeckS.OlivaB.GabrielG.Alternative interaction sites in the influenza A"/>
 <result pre="mediated nuclear import pathwayFEBS J.28620193374338831044563 RoohvandF.MaillardP.LavergneJ.P.BoulantS.WalicM.AndreoU.GoueslainL.HelleF.MalletA.McLauchlanJ.Initiation of hepatitis C virus" exact="infection" post="requires the dynamic microtubule network: role of the viral"/>
</results>
